Hepatic abnormalities in youth with Turner syndrome.
PEDSnet
Turner syndrome
fatty liver disease
hormone replacement therapy
mosaicism
transaminases
Journal
Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
revised:
17
06
2022
received:
29
09
2021
accepted:
01
07
2022
pubmed:
6
7
2022
medline:
1
9
2022
entrez:
5
7
2022
Statut:
ppublish
Résumé
Liver disease in children with Turner Syndrome (TS) is poorly understood relative to associated growth, cardiac and reproductive complications. This study sought to better characterize hepatic abnormalities in a large national cohort of youth with TS. Using electronic health record data from PEDSnet institutions, 2145 females with TS were matched to 8580 females without TS on eight demographic variables. Outcomes included liver enzymes (AST and ALT) stratified as normal, 1-2 times above the upper limit of normal (ULN), 2-3 times ULN and >3 times ULN, as well as specific liver disease diagnoses. Fifty-eight percent of youth with TS had elevated liver enzymes. Patients with TS had higher odds of enzymes 1-2 times ULN (OR: 1.7, 95% CI: 1.4-1.9), 2-3 times ULN (OR: 2.7, 95% CI: 1.7-3.3) and >3 times ULN (OR: 1.7, 95% CI: 1.3-2.2). They also had higher odds of any liver diagnosis (OR: 2.4, 95% CI: 1.7-3.3), fatty liver disease (OR: 1.9, 95% CI: 1.1-3.2), hepatitis (OR: 3.7, 95% CI: 1.9-7.1), cirrhosis/fibrosis (OR: 5.8, 95% CI: 1.3-25.0) and liver tumour/malignancy (OR: 4.8, 95% CI: 1.4-17.0). In a multinomial model, age, BMI and presence of cardiovascular disease or diabetes significantly increased the odds of elevated liver enzymes in girls with TS. Youth with TS have higher odds for elevated liver enzymes and clinically significant liver disease compared with matched controls. These results emphasize the need for clinical screening and additional research into the aetiology and treatment of liver disease in TS. Turner Syndrome, a chromosomal condition in which females are missing the second sex chromosome, is often associated with short stature, infertility and cardiac complications. Liver abnormalities are less well described in the literature. In this study, nearly 60% of youth with TS have elevated liver enzymes. Furthermore, patients with TS had a diagnosis of liver disease more often than patients without TS. Our results support the importance of early and consistent liver function screening and of additional research to define mechanisms that disrupt liver function in paediatric TS females.
Sections du résumé
BACKGROUND & AIMS
Liver disease in children with Turner Syndrome (TS) is poorly understood relative to associated growth, cardiac and reproductive complications. This study sought to better characterize hepatic abnormalities in a large national cohort of youth with TS.
METHODS
Using electronic health record data from PEDSnet institutions, 2145 females with TS were matched to 8580 females without TS on eight demographic variables. Outcomes included liver enzymes (AST and ALT) stratified as normal, 1-2 times above the upper limit of normal (ULN), 2-3 times ULN and >3 times ULN, as well as specific liver disease diagnoses.
RESULTS
Fifty-eight percent of youth with TS had elevated liver enzymes. Patients with TS had higher odds of enzymes 1-2 times ULN (OR: 1.7, 95% CI: 1.4-1.9), 2-3 times ULN (OR: 2.7, 95% CI: 1.7-3.3) and >3 times ULN (OR: 1.7, 95% CI: 1.3-2.2). They also had higher odds of any liver diagnosis (OR: 2.4, 95% CI: 1.7-3.3), fatty liver disease (OR: 1.9, 95% CI: 1.1-3.2), hepatitis (OR: 3.7, 95% CI: 1.9-7.1), cirrhosis/fibrosis (OR: 5.8, 95% CI: 1.3-25.0) and liver tumour/malignancy (OR: 4.8, 95% CI: 1.4-17.0). In a multinomial model, age, BMI and presence of cardiovascular disease or diabetes significantly increased the odds of elevated liver enzymes in girls with TS.
CONCLUSIONS
Youth with TS have higher odds for elevated liver enzymes and clinically significant liver disease compared with matched controls. These results emphasize the need for clinical screening and additional research into the aetiology and treatment of liver disease in TS.
LAY SUMMARY
Turner Syndrome, a chromosomal condition in which females are missing the second sex chromosome, is often associated with short stature, infertility and cardiac complications. Liver abnormalities are less well described in the literature. In this study, nearly 60% of youth with TS have elevated liver enzymes. Furthermore, patients with TS had a diagnosis of liver disease more often than patients without TS. Our results support the importance of early and consistent liver function screening and of additional research to define mechanisms that disrupt liver function in paediatric TS females.
Identifiants
pubmed: 35785515
doi: 10.1111/liv.15358
pmc: PMC9798872
mid: NIHMS1860460
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2237-2246Subventions
Organisme : NICHD NIH HHS
ID : K23 HD092588
Pays : United States
Organisme : NICHD NIH HHS
ID : R03 HD102773
Pays : United States
Informations de copyright
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Endocr Connect. 2019 Nov;8(11):1483-1492
pubmed: 31627185
BMJ. 1998 Aug 1;317(7154):307-12
pubmed: 9685274
Eur J Pediatr. 2000 Mar;159(3):143-8
pubmed: 10664223
Clin Endocrinol (Oxf). 2018 Nov;89(5):667-676
pubmed: 29992593
PLoS One. 2010 Dec 08;5(12):e14254
pubmed: 21170382
J Am Med Inform Assoc. 2014 Jul-Aug;21(4):602-6
pubmed: 24821737
J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1089-93
pubmed: 18557801
Hepatology. 2004 Jan;39(1):239-47
pubmed: 14752843
Eur J Endocrinol. 2007 Jun;156(6):679-86
pubmed: 17535868
J Autoimmun. 2012 Jun;38(4):315-21
pubmed: 22342295
Diabetes Care. 2007 Oct;30(10):2566-8
pubmed: 17626893
Clin Endocrinol (Oxf). 2008 Aug;69(2):306-10
pubmed: 18248644
Hepatology. 2018 Oct;68(4):1319-1330
pubmed: 28926121
Gastroenterol Hepatol (N Y). 2011 May;7(5):337-9
pubmed: 21857837
Stat Med. 2014 Mar 15;33(6):1057-69
pubmed: 24123228
Eur J Endocrinol. 2017 Sep;177(3):G1-G70
pubmed: 28705803
Pediatrics. 2016 Feb;137(2):e20152232
pubmed: 26746404
Clin Endocrinol (Oxf). 2001 Aug;55(2):227-31
pubmed: 11531930
Endocr Rev. 2012 Oct;33(5):677-714
pubmed: 22707402
Liver Int. 2013 Jan;33(1):24-30
pubmed: 23121401
Horm Res Paediatr. 2019;92(5):328-334
pubmed: 31563903
J Clin Res Pediatr Endocrinol. 2019 May 23;11(4):395-399
pubmed: 31117336
Clin Gastroenterol Hepatol. 2004 Feb;2(2):107-12
pubmed: 15017614
Aliment Pharmacol Ther. 2021 Apr;53(7):821-829
pubmed: 33550624
J Clin Endocrinol Metab. 1997 Aug;82(8):2570-7
pubmed: 9253336
Am Fam Physician. 2005 Mar 15;71(6):1105-10
pubmed: 15791889